SLS Stock Hits Over 5-Year High: Retail Traders Bet Big On Breaking $25 As AML Readout Looms
Shares of Sellas Life Sciences (SLS) hit their highest level in over five years on Monday as retail traders showed strong confidence in the stock’s 12-month upside ahead of the company’s closely watched acute myeloid leukemia (AML) trial readout.SLS stock jumped 25% on Monday to close at $15.45, ex…